Skip to main content

Name withheld, LPN

Consent agreement

Jan 22, 2023

On January 22, 2023, a panel of the Inquiry Committee approved a Consent Agreement between BCCNM and the Registrant related to a significant history of diverting narcotics for self-use from patients under their care between 2015 and 2022. The Registrant voluntarily disclosed their diversion to a physician when notified of an employer investigation into medication tampering. This disclosure ensured that their medical diagnosis and subsequent prognosis and treatment recommendations matched the extent of their substance use disorder, providing a greater likelihood of treatment success. The extent of the disclosure was considered mitigating by the Inquiry Committee panel. The Registrant was diagnosed with, and admitted to a disability with a causal relationship to the conduct issues via an independent medical report and has agreed to comply with treatment recommendations.

The Registrant has voluntarily agreed to terms equivalent to limits and/or conditions on their practice, including:

  1. A suspension of nursing registration for 3 months;

  2. Compliance with recommendations of their treating specialist;

  3. Disclosure of treatment recommendations to relevant employer representative(s);

  4. A limit impacting access to and handling of narcotics, with concurrent medical monitoring, to support the stable return to fitness to practice;

  5. Limits on working overtime, night shifts, practising in high acuity or critical care areas, and providing care in client's homes.

The Agreement will remain in place for a minimum of 5 years of continuous nursing practice. The name of the Registrant has been withheld in accordance with section 39.3 (4) (a) of the Health Professions Act for the purposes of not identifying the personal health information of the Registrant respecting the condition.

The Inquiry Committee is satisfied that the terms will protect the public.